Insilico Medicine Unveils First AI-Generated and AI-Discovered Drug, Transforming Drug Discovery

Jul 29, 2024, 11:01 AM

Insilico Medicine has unveiled the first AI-generated and AI-discovered drug, marking a significant milestone in the field of drug discovery. The use of AI in drug discovery is revolutionizing the pharmaceutical industry by accelerating candidate identification, reducing lab costs, and shortening timelines. Companies like Amgen, Terray Therapeutics, and Nested Therapeutics, in collaboration with Inductive Bio, are leveraging machine learning models to optimize small molecules and overcome critical ADME issues. This advancement in AI technology is expected to significantly impact the traditional 10-12 year drug discovery cycle, potentially transforming the entire ecosystem. The Broad Institute and Syngenta are also contributing to this transformative approach in drug discovery.